Interhem Opieka Szpitalna

Bialystok 15748

0 studies enrolling now · 2 studies all time

What they study most

B-cell Malignancies, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Studies at this site

• Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies — Running, not enrolling
• A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia — Completed